Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000926617-19-000017
Filing Date
2019-05-09
Accepted
2019-05-09 17:11:33
Documents
3
Period of Report
2019-05-09
Effectiveness Date
2019-05-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A vrml-20190509xdef14a.htm DEF 14A 1174301
2 GRAPHIC vrml-20190509xdef14ag001.jpg GRAPHIC 11749
3 GRAPHIC vrml-20190509xdef14ag002.jpg GRAPHIC 7939
  Complete submission text file 0000926617-19-000017.txt   1203039
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34810 | Film No.: 19811721
SIC: 2835 In Vitro & In Vivo Diagnostic Substances